Ultrastructural alterations in capillaries of the diabetic hypertensive rat retina: Protective effects of ACE inhibition

Diabetologia

Volumn 47, Issue 7, 2004, Pages 1196-1201

  Dosso, A A ^a   Rungger Brandle E ^a   Leuenberger, P M ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

ACE inhibitor; Capillaries; Diabetic hypertensive rat; Diabetic retina; Ultrastructural morphometry

Indexed keywords

CILAZAPRIL; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; CAPILLARY BASEMENT MEMBRANE; CELL JUNCTION; CONTROLLED STUDY; DIABETIC HYPERTENSION; DRUG EFFECT; ENDOTHELIUM CELL; ENZYME INHIBITION; EXTRACELLULAR MATRIX; EYE PROTECTION; GLUCOSE BLOOD LEVEL; HYPERTENSION RETINOPATHY; MALE; MORPHOMETRICS; NONHUMAN; PERICYTE; PRIORITY JOURNAL; RAT; RAT STRAIN; RETINA CAPILLARY; SPONTANEOUSLY HYPERTENSIVE RAT; STREPTOZOCIN DIABETES; SYSTOLIC BLOOD PRESSURE;

EID: 4143135497     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-004-1442-3     Document Type: Article

References (54)

1. Klein R, Klein BEK, Moss SE (1984) Visual impairment in diabetes. Ophthalmology 91:1-9
2. Orchard TJ, Dorman JS, Maser RE et al. (1990) Prevalence of complications in IDDM by sex and duration. Pittsburgh Epidemiology of Diabetes Complications Study II. Diabetes 39:1116-1124
3. Dwyer MS, Melton LJ, Ballard DJ, Palumbo PJ, Trautmann JC, Chu CP (1985) Incidence of diabetic retinopathy and blindness: a population-based study in Rochester, Minnesota. Diabetes Care 8:316-322
4. Moss SE, Klein R, Klein BE (1988) The incidence of vision loss in a diabetic population. Ophthalmology 95:1340-1348
5. Porta M, Tomalino MG, Santoro F, Ghigo LD, Cairo M, Aimone M (1995) Diabetic retinopathy as a case of blindness in the province of Turin, north-west Italy, in 1967-1991. Diabetic Med 12:355-361
6. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL (1984) The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 102:520-526
7. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL (1984) The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 102:527-532
8. Klein R, Klein BEK, Moss SE (1992) Epidemiology of proliferative diabetic retinopathy. Diabetes Care 15:1875-1891
9. Control and Complications Trial Research Group (DCCT) (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986
10. Teuscher A, Egger M, Herman JB (1989) Diabetes and hypertension: blood pressure in clinical diabetic patients and a control population. Arch Intern Med 149:1942-1945
11. Klein R, Klein BEK, Le KE, Cruickshanks KJ, Moss SE (1996) The incidence of hypertension in insulin-dependent diabetes. Arch Intern Med 156:622-627
12. Parving H-H (1991) Impact of blood pressure and antihypertensive treatment on incipient and overt nephropathy, retinopathy, and endothelial permeability in diabetes mellitus. Diabetes Care 14:260-269
13. Janka HU, Ziegler AG, Valsania P, Warram JH, Krolewski AS (1989) Impact of blood pressure on diabetic retinopathy. Diabetes Metab 15:333-337
14. Klein BEK, Klein R, Moss SE, Palta M (1995) A cohort study of the relationship of diabetic retinopathy to blood pressure. Arch Ophthalmol 113:601-606
15. Weidmann P, Böhlen LM, de Courten M (1993) Pathogenesis and treatment of hypertension associated with diabetes mellitus. Am Heart J 125:1498-1513
16. Parving H-H, Larsen M, Hommel E, Lund-Andersen H (1989) Effect of antihypertensive treatment on blood-retinal barrier permeability to fluorescein in hypertensive Type 1 (insulin-dependent) diabetic patients with background retinopathy. Diabetologia 32:440-444
17. Gin T, Joon TL, Panagiotopoulos S, Cooper M, Taylor H, Jerums G (1996) Organ specificity of antihypertensive therapy on ocular albumin vascular clearance and albumin-uria in the hypertensive diabetic rat. Invest Ophthalmol Vis Sci 37:281-289
18. UK Prospective Diabetes Study Group (1998) Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. BMJ 317:713-720
19. Satcher R, Dewey CF Jr, Hartwig JH (1997) Mechanical remodeling of the endothelial surface and actin cytoskeleton induced by fluid flow. Microcirculation 4:439-453
20. Hansen-Smith F, Greene AS, Cowley AW, Lombard JH (1990) Structural changes during microvascular rarefaction in chronic hypertension. Hypertension 15:922-928
21. Larsen M, Hommel E, Parving H-H, Lund-Andersen H (1990) Protective effect of captopril on the blood-retinal barrier in normotensive insulin-dependent diabetic patients with nephropathy and background retinopathy. Graefes Arch Clin Exp Ophthalmol 228:505-509
22. +-ATPase activity in the retina of streptozotocin-induced diabetic rats. Invest Ophthalmol Vis Sci 37:1633-1641
23. Chaturvedi N, Sjolie A-K, Stephenson JM, the EUCLID Study Group (1998) Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. Lancet 351:28-31
24. Danser AHJ, van den Dorpel MA, Deinum J et al. (1989) Renin, prorenin, and immunoreactive renin in vitreous fluid from eyes with and without diabetic retinopathy. J Clin Endocrinol Metab 68:160-167
25. Schalekamp MADH (1993) Renin-angiotensin system components and endothelial proteins as markers of diabetic microvascular disease. Clin Invest 71:S3-S6
26. Ferrari-Dileo G, Davis EB, Anderson DR (1987) Angiotensin binding sites in bovine and human retinal blood vessels. Invest Ophthalmol Vis Sci 28:1747-1751
27. Brown SM, Jampol LM (1996) New concepts of regulation of retinal vessel tone. Arch Ophthalmol 114:199-204
28. +-ATPase in diabetes: Streptozotocin-induced and Zucker diabetic fatty rats. Curr Eye Res 12:1111-1121
29. Dosso AA, Leuenberger PM, Rungger-Brändle E (1999) Remodeling of retinal capillaries in the diabetic hypertensive rat. Invest Ophthalmol Vis Sci 40:2405-2410
30. Sachs L (1992) Angewandte Statistik. 7th edn. Springer, Berlin Heidelberg
31. Berka JL, Stubbs AJ, Wang DZ et al. (1995) Renin-containing Muller cells of the retina display endocrine features. Invest Ophthalmol Vis Sci 36:1450-1458
32. Kohler K, Wheeler-Schilling T, Jurklies B, Guenther E, Zrenner E (1997) Angiotensin II in the rabbit retina. Vis Neurosci 14:63-71
33. Murata M, Nakagawa M, Takahashi S (1997) Angiotensinogen mRNA is synthesized locally in rat ocular tissues. Ophthalmologica 211:301-304
34. Wagner J, Jan Danser AH, Derkx FH et al. (1996) Demonstration of renin mRNA, angiotensinogen mRNA, and angiotensin converting enzyme mRNA expression in the human eye: evidence for an intraocular renin-angiotensin system. Br J Ophthalmol 80:159-163
35. Gilbert RE, Krumt H, Wilkinson-Berka J, Kelly DJ (2003) The renin-angiotensin system and the long-term complications of diabetes: pathophysiological and therapeutic considerations. Diabet Med 20:607-621
36. Sinclair SH, Grunwald JE, Riva C, Braunstein SL, Nichols CW, Schwartz S (1982) Retinal vascular autoregulation in diabetes mellitus. Ophthalmology 89:748-750
37. Ottlez A, Bensaoula T, Eichberg J, Peterson RG (1996) Angiotensin-converting enzyme activity in retinas of streptozotocin-induced and zucker diabetic rats. Invest Ophthalmol Vis Sci 37:2157-2164
38. Patel V, Rassam SMB, Chen HC, Jones M, Kohner EM (1998) Effect of angiotensin-converting enzyme inhibition with perindopril and b-blockade with atenolol on retinal blood flow in hypertensive diabetic subjects. Metabolism 47:28-33
39. Luetscher JA, Kreamer FB, Wilson DM (1989) Prorenin and vascular complications of diabetes. Am J Hypertens 2:382-386
40. +-ATPase activity in rabbit aorta by hyperglycemia. J Clin Invest 90:727-732
41. Bui BV, Armitage JA, Tolcos M, Cooper ME, Vingrys AJ (2003) ACE inhibition salvages the visual loss caused by diabetes. Diabetologia 46:401-408
42. Gilbert RE, Vranes D, Berka JL et al. (1998) Vascular endothelial growth factor and its receptors in control and diabetic rats eyes. Lab Invest 78:1017-1027
43. Gilbert RE, Kelly DJ, Cox AJ et al. (2000) Angiotensin converting enzyme inhibition reduces retinal overexpression of vascular endothelial growth factor and hyperpermeability in experimental diabetes. Diabetologia 43:1360-1367
44. Moravski CJ, Skinner SL, Stubbs AJ et al. (2003) The renin-angiotensin system influences ocular endothelial cell proliferation in diabetes. Am J Pathol 162:151-160
45. Blobe CB, Schiemann WP, Lodish HF (2000) Role of transforming growth factor-beta in human disease. N Engl J Med 342:1350-1360
46. Ziyadeh FN, Sharma K, Ericksen M, Wolf G (1994) Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-beta. J Clin Invest 93:536-542
47. Kagami S, Border WA, Miller DE, Noble NA (1994) Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells. J Clin Invest 93:2431-2437
48. Wolf G, Haberstroh U, Neilson EG (1992) Angiotensin II stimulates the proliferation and biosynthesis of type I collagen in cultured murine mesangial cells. Am J Pathol 140:95-107
49. Ray PE, Bruggeman LA, Horikoshi S, Aguilera G, Klotman PE (1994) Angiotensin II stimulates human fetal mesangial cell proliferation and fibronectin biosynthesis by binding to AT1 receptors. Kidney Int 45:177-184
50. Singh R, Alavi N, Singh AK, Leehey DJ (1999) Role of angiotensin II in glucose-induced inhibition of mesangial matrix degradation. Diabetes 48:2066-2073
51. Nakamura T, Takahashi T, Fukui M et al. (1995) Enalapril attenuates increased gene expression of extracellular matrix components in diabetic rats. J Am Soc Nephrol 5:1492-1497
52. Kalender B, Ozturk M, Tuncdemir M et al. (2002) Reno-protective effects of valsartan and enalapril in STZ-induced diabetes in rats. Acta Histochem 104:123-130
53. Volpini RA, da Silva CG, Costa RS, Coimbra TM (2003) Effect of enalapril and losartan on the events that precede diabetic nephropathy in rats. Diabetes Metab Res Rev 19:43-51
54. Zhang J-Z, Gao L, Widness M, Xi X, Kern TS (2003) Captopril inhibits glucose accumulation in retinal cells in diabetes. Invest Ophthalmol Vis Sci 44:4001-4005